Skip to content

Colchicine Treatment for Chronic Shoulder Pain Related to Calcific Tendonitis

Colchicine Treatment for Chronic Shoulder Pain Related to Calcific Tendonitis: Double Blind Placebo-controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00983177
Enrollment
80
Registered
2009-09-23
Start date
2010-03-31
Completion date
2011-10-31
Last updated
2010-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcific Tendonitis

Brief summary

Chronic pain due to calcific tendonitis of shoulder is a prevalent condition usually treated with recurrent courses of NSAIDs, physical therapy or surgical interventions. Colchicine has been reported to be effective in the acute attack of shoulder tendonitis, however, has never been examined in controlled study in patients with chronic shoulder pain secondary to calcific tendonitis. Eighty patients with chronic shoulder pain (at least 3 months duration) due to calcific tendonitis will be randomized to receive colchicine 0.5 mg twice daily or placebo (lactose capsules) for 4 months. At the end of this blinded part of the study, patients who received placebo and did not improve, will be eligible to continue study in the open mode for additional 4 months with study drug. Efficacy (VAS for shoulder pain, shoulder range of motion and shoulder pain and disability index) and safety (blood tests) follow-ups will be scheduled bi-monthly for all patients.

Interventions

DRUGColchicine

0.5 mg twice daily for 4 months

DRUGlactose

lactose capsules twice daily

Sponsors

Bnai Zion Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chronic, more than 3 months duration, shoulder pain * tendinous calcifications on shoulder X-rays

Exclusion criteria

* renal insufficiency * liver insufficiency * lactose intolerance * hypersensitivity to colchicine

Design outcomes

Primary

MeasureTime frame
VAS for shoulder pain4-8 months
shoulder range of motion4-8 months
shoulder pain and disability index4-8 months

Countries

Israel

Contacts

Primary ContactGleb Slobodin, MD
gleb.slobodin@b-zion.org.il972-506267284

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026